Cargando…
Designation Products: Boron Neutron Capture Therapy for Head and Neck Carcinoma
The Japanese Ministry of Health, Labour and Welfare approved a drug called borofalan ((10)B), a treatment system, and a dose calculation program for boron neutron capture therapy (BNCT) in March 2020. The application pertaining to the products submitted to the Pharmaceuticals and Medical Devices Age...
Autores principales: | Kanno, Hitoshi, Nagata, Hironori, Ishiguro, Akihiro, Tsuzuranuki, Satoshi, Nakano, Shintaro, Nonaka, Takahiro, Kiyohara, Koushin, Kimura, Toshinari, Sugawara, Akihiko, Okazaki, Yuzuru, Takae, Shinichi, Nakabayashi, Tetsuo, Arai, Hiroyuki, Suzuki, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265361/ https://www.ncbi.nlm.nih.gov/pubmed/33928712 http://dx.doi.org/10.1002/onco.13805 |
Ejemplares similares
-
Recent progress to shorten premarket evaluation and improve patient access to medical devices by the Pharmaceuticals and Medical Devices Agency of Japan
por: Handa, Nobuhiro, et al.
Publicado: (2019) -
Evaluation of reoperations for removal of bioabsorbable plates and screws based on adverse events reports from PMDA, Japan
por: Kobayashi, Tomoko, et al.
Publicado: (2020) -
Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010) -
Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011) -
Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)